<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03841149</url>
  </required_header>
  <id_info>
    <org_study_id>NI18037J</org_study_id>
    <secondary_id>2018-A01394-51</secondary_id>
    <nct_id>NCT03841149</nct_id>
  </id_info>
  <brief_title>Volume 3D_US Kidney</brief_title>
  <acronym>VolUS3D</acronym>
  <official_title>Measurement of Kidney Volume and Renal Tumor Volume Using 3D-Ultrasound Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the volume of the kidney and tumors using 3D-US&#xD;
      acquisition and to correlate these measurements to contrast-enhanced CT or MRI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Additional objectives are comparison between true volume measurements and volume estimation&#xD;
      using measurements of the three perpendicular diameters, comparison of inter and intra&#xD;
      variability of 3D US measurements with inter and intra variability of 3D CT or MRI&#xD;
      measurements, calculation of 3D and 2D volume measurements during contrast-enhanced US&#xD;
      examination when the injection is performed for clinical routine purposes such as vascular&#xD;
      and extension staging, during interventional procedures such as US guided biopsy targeting&#xD;
      the non-necrotic tumour parenchyma. Concordance between 2D and 3D US acquisitions will be&#xD;
      compared to CT and MRI measurements. Comparison of volume measurements between non-contrast&#xD;
      and contrast-enhanced methods (US, CT and MRI) will be performed. The results will be&#xD;
      compared to renal function before and after tumour treatment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 29, 2020</start_date>
  <completion_date type="Anticipated">September 29, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 29, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>3D-US volume measurements</measure>
    <time_frame>1 month</time_frame>
    <description>Kidney and renal tumor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>2D-US volume measurements</measure>
    <time_frame>1 month</time_frame>
    <description>Kidney and renal tumor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inter and intra variability measurements</measure>
    <time_frame>1 month</time_frame>
    <description>Kidney and renal tumor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2D and 3D US volume measurements during Contrast-enhanced US (if performed for patient management)</measure>
    <time_frame>1 month</time_frame>
    <description>Kidney and renal tumor</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Chronic Kidney Diseases</condition>
  <condition>Renal Tumor</condition>
  <arm_group>
    <arm_group_label>VolUS3D patients</arm_group_label>
    <description>Patients with renal tumour</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound Imaging</intervention_name>
    <description>3D volume calculation using on-line and off-line softwares</description>
    <arm_group_label>VolUS3D patients</arm_group_label>
    <other_name>3D Ultrasound transducer and fusion imaging</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients (n=80) referred for renal tumour management (including imaging, biopsy or&#xD;
        percutaneous ablation)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patient (age 18)&#xD;
&#xD;
          -  Absence of participant's opposition&#xD;
&#xD;
          -  No contra-indication to contrast-enhanced CT AND MRI (a single contrast-enhanced&#xD;
             imaging modality is sufficient)&#xD;
&#xD;
          -  Affiliated to Social Security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Contra-indication to both contrast-enhanced CT AND MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel Correas, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Michel Correas, PU-PH</last_name>
    <phone>+33 1 44 49 41 40</phone>
    <email>jean-michel.correas@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène Morel</last_name>
    <phone>+33 1 71 19 63 46</phone>
    <email>helene.morel@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Necker-Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel Correas, PU-PH</last_name>
      <phone>+33 1 44 49 41 40</phone>
      <email>jean-Michel.correas@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 12, 2019</study_first_submitted>
  <study_first_submitted_qc>February 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>3D Ultrasound volume measurements</keyword>
  <keyword>Renal volume</keyword>
  <keyword>Tumour Volume</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

